- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: MISTRAL.
Displaying page 1 of 1.
| EudraCT Number: 2014-004552-64 | Sponsor Protocol Number: 131016 | Start Date*: 2017-07-03 |
| Sponsor Name:Center for Digestive Diseases, Karolinska University Hospital | ||
| Full Title: MISTRAL - Mistletoe therapy in primary and recurrent inoperable pancreatic cancer - A phase III prospective, randomized, double blinded, multicenter, parallel group, placebo controlled clinical tr... | ||
| Medical condition: Primary or recurrent inoperable pancreatic cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005738-11 | Sponsor Protocol Number: CRAD001C2445 | Start Date*: 2006-08-23 |
| Sponsor Name:Unidad integral de investigación en oncologia | ||
| Full Title: Phase II Study of Single Agent RAD001 in Patients with Colon Cancer and Activating Mutations in the PI3KCA gene. | ||
| Medical condition: Colon Cancer | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-001747-18 | Sponsor Protocol Number: ML 21421 | Start Date*: 2008-06-05 | |||||||||||
| Sponsor Name:ROCHE | |||||||||||||
| Full Title: Etude multicentrique évaluant le maintien du taux d’hémoglobine avec une administration sous-cutanée mensuelle de C.E.R.A. (activateur continu du récepteur de l’érythropoïétine) chez des patients i... | |||||||||||||
| Medical condition: Patients insuffisants rénaux chroniques sous dialyse péritonéale | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-014586-75 | Sponsor Protocol Number: D0520C00020 | Start Date*: 2009-12-21 | |||||||||||
| Sponsor Name:AstraZeneca AB | |||||||||||||
| Full Title: A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multinational, Phase IIb Study to Evaluate the Efficacy and Safety of 60 mg AZD9668 Administered Orally Twice Daily to Subje... | |||||||||||||
| Medical condition: Chronic Obstructive Pulmonary Disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) CZ (Completed) SK (Completed) BG (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.